Adze Biotechnology
PrivateLast Round
Series A
Mar 16, 2023
Total Funding Raised
$6.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adze Biotechnology is a biotechnology company developing a platform of immunotherapies that treat solid tumors and develop a robust anti-tumor immunity for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adze Biotechnology Comparables
Compare Adze Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 86% | |
| Lokon Pharma | 83% | |
| Akamis Bio | 82% |
Adze Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 16, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 86% MoM, reaching 1.3K.
- May 17, 2026
Monthly visitors increased 36% MoM.
Adze Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Adze Biotechnology's valuation, stock price, and market status.
Is Adze Biotechnology a public or private company?
Adze Biotechnology is a private company.
What is the current stock price of Adze Biotechnology?
Adze Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Adze Biotechnology worth (valuation)?
Valuation information for Adze Biotechnology is not publicly available.
Can I buy Adze Biotechnology stock?
Adze Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Adze Biotechnology's last funding round?
Adze Biotechnology's most recent funding round was Series A on March 16, 2023.
Who are the main investors in Adze Biotechnology?
Investor information for Adze Biotechnology is not publicly disclosed.
Will Adze Biotechnology IPO soon?
No public IPO plans have been announced for Adze Biotechnology.
How can I track Adze Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Adze Biotechnology's secondary market activity and sign up for updates.